Masimo Corporation (MASI)
Masimo Corporation (MASI) is a global healthcare technology company known for developing innovative non-invasive monitoring solutions. Founded in 1989, it specializes in pulse oximetry, patient monitoring, and anesthesia delivery systems, aiming to improve patient outcomes through advanced sensing and data analysis technologies.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 11, 2012 | $1.00 | 2012-11-23 | 2012-11-27 |
| December 21, 2010 | $0.75 | 2010-12-03 | 2010-12-07 |
| March 31, 2010 | $2.00 | 2010-03-09 | 2010-03-11 |
Dividends Summary
- Masimo Corporation has issued 3 dividend payments over the past 2 years
- The most recent dividend was paid 4698 days ago, on December 11, 2012
- The highest dividend payed out to investors during this period was $2.00 per share
- The average dividend paid during this period was $1.25 per share.
Company News
The global neonatal infant care market is projected to grow from $3.63 billion in 2025 to $6.70 billion by 2034, driven by rising preterm birth rates and advanced NICU technologies. North America leads the market, while Asia Pacific shows the fastest growth.
Masimo, a medical tech company, announced that its CEO Joe Kiani has stepped down, and board member Michelle Brennan has been appointed as interim CEO. The company has launched a search for a permanent CEO.
Intuitive Surgical reported strong second-quarter 2024 results, with adjusted earnings and revenue beating estimates. The company's da Vinci procedure volume growth and higher pricing contributed to the top-line improvement. Intuitive Surgical also saw increased system placements, including its latest da Vinci 5 systems.
The upcoming Apple Watch Series 10 may not include anticipated health features like blood pressure monitoring and sleep apnea detection due to technical and legal issues. However, Apple is making progress on glucose monitoring technology.
Speculation about Apple's near future comes against the backdrop of the U.S. Supreme Court's decision Jan. 16 not to hear appeals of an antitrust ruling on Epic Games Inc.'s lawsuit over App Store policies.
